ANO1 and gastric cancer: However, TMEM16A inhibition by shRNAs or pharmacological inhibitors does not affect cell proliferation in BHY HNSCC cells, GIST cells, pancreatic ductal adenocarcinoma cells and gastric cancer cells [45, 54, 92, 93].